MétaCan
Menu
Back to cohort
Record W4408216090 · doi:10.1101/2025.03.06.25323518

Hyperkalemia-related Heart Failure Therapy Discontinuation and the Association with Outcomes in Patients with Heart Failure

2025· preprint· en· W4408216090 on OpenAlexafffundabout
Aanchel Gupta, Sunjidatul Islam, Douglas C. Dover, Padma Kaul, Finlay A. McAlister, Justin A. Ezekowitz

Bibliographic record

VenuemedRxiv · 2025
Typepreprint
Languageen
FieldMedicine
TopicPotassium and Related Disorders
Canadian institutionsCanadian VIGOUR CentreUniversity of Alberta
FundersCanadian Institutes of Health ResearchAlberta InnovatesUniversity of AlbertaAlberta Health Services
KeywordsDiscontinuationHyperkalemiaHeart failureMedicineInternal medicineCardiologyIntensive care medicine

Abstract

fetched live from OpenAlex

Abstract Background Renin-angiotensin-aldosterone system (RAAS) inhibitors are essential treatments for heart failure (HF) patients, but their use is often limited by hyperkalemia. Objective This study assesses the incidence of hyperkalemia in chronic HF patients on RAAS inhibitors, examines changes in therapy following hyperkalemia episodes, and evaluates the impact of RAAS inhibitor discontinuation or down-titration on patient outcomes. Methods We conducted a population-based cohort study of patients hospitalized or visiting the emergency department in Alberta for chronic HF from April 2012 to March 2020, focusing on those with RAAS inhibitor-associated hyperkalemia. Episodes of hyperkalemia (K >5.0 mmol/L) were monitored, and patients were followed for 30 days to determine if their RAAS therapy was maintained, reduced, or discontinued. Results Among 7527 HF patients, we identified 123,038 RAAS inhibitor treatment years, resulting in 17 hyperkalemia events per 100 treatment years. Hyperkalemia led to RAAS inhibitor discontinuation in 35.2% of cases, down-titration in 8.4%, and continuation in 56.4%. Discontinuation or down-titration was more common when serum potassium exceeded 6.0 mmol/L (49.4%) compared to lower levels. Over a median follow-up of 1.4 years, discontinuing or down-titrating RAAS inhibitors was associated with increased all-cause mortality (aHR 1.80), higher cardiovascular hospitalizations (aHR 1.09), and more frequent ED visits for HF (aHR 1.17) compared to continued therapy. Conclusions Discontinuation or down-titration of RAAS inhibitors in HF patients is associated with higher mortality and cardiovascular events. Strategies to maintain RAAS therapy after hyperkalemia episodes may improve patient outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.040
Threshold uncertainty score0.736

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.221
Teacher spread0.216 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes3
Has abstractyes

Explore more

Same venuemedRxivSame topicPotassium and Related DisordersFrench-language works237,207